Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.07 +0.10 (+2.39%)
As of: Nov 11, 2026 · 1:35 PM EST

Oramed Pharmaceuticals (ORMP) Selling, General & Administrative (2009 - 2026)

Updated

Oramed Pharmaceuticals (ORMP) reported Selling, General & Administrative of $2.77 million for Q2 2026, up 90.1% from $1.46 million a year earlier and up 33.9% from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) Selling, General & Administrative (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Oramed Pharmaceuticals' Selling, General & Administrative came in at $9.79 million, up 45.2% year-over-year; for FY2025, it came in at $8.72 million, up 35.0% from FY2024.

  • Selling, General & Administrative has a three-year compound annual growth rate of -14.2% (FY2022 to FY2025).
  • By year, Selling, General & Administrative came in at $6.46 million in FY2024 (-23.4%), $8.43 million in FY2023 (-39.0%) and $13.81 million in FY2022.
  • Five-year quarterly Selling, General & Administrative spans a low of $847,000 in Q3 2024 and a high of $5.49 million in Q1 2022.
  • Year over year, Selling, General & Administrative gained in five of the last eight quarters, with growth averaging 19.0%.
  • The high point for year-over-year Selling, General & Administrative in five years was Q2 2026 (growth of 90.1%); the low point was Q1 2023 (a decline of 77.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.07 million (Q1 2026), $3.68 million (Q4 2025) and $1.27 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.13 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 6.29 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.09 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.89 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 5.11 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.68 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.64 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 3.28 Bn
10 Oramed Pharmaceuticals 164.02 Mn -170.72 Mn - 2.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.77 Mn
Mar 31, 2026 2.07 Mn
Dec 31, 2025 3.68 Mn
Sep 30, 2025 1.27 Mn
Jun 30, 2025 1.46 Mn
Mar 31, 2025 2.31 Mn
Dec 31, 2024 2.13 Mn
Sep 30, 2024 847,000.00
Jun 30, 2024 1.69 Mn
Mar 31, 2024 1.78 Mn
Dec 31, 2023 2.11 Mn
Sep 30, 2023 2.60 Mn
Jun 30, 2023 2.45 Mn
Mar 31, 2023 1.26 Mn
Dec 31, 2022 2.73 Mn
Sep 30, 2022 3.06 Mn
Jun 30, 2022 2.53 Mn
Mar 31, 2022 5.49 Mn
Nov 30, 2021 1.74 Mn
May 31, 2021 1.30 Mn
API Access

Oramed Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ORMP&period=max&api_key=YOUR_API_KEY